Parapsoriasis
Showing 1 - 22 of 22
Mycosis Fungoides of Skin Trial in Istanbul (videodermoscopy, lesional capillaroscopy)
Completed
- Mycosis Fungoides of Skin
- videodermoscopy, lesional capillaroscopy
-
Istanbul, Istanbul/Fatih, TurkeyIstanbul Teaching and Research Hospital
Jun 28, 2022
Parapsoriasis, Healthy Volunteers Trial in Austin (CC-90005, Placebo)
Terminated
- Parapsoriasis
- Healthy Volunteers
- CC-90005
- Placebo
-
Austin, TexasPPD Development, LP
Nov 14, 2019
Parapsoriasis Trial in Reamat- Gan (natural gels, Placebo)
Completed
- Parapsoriasis
- natural gels
- Placebo
-
Reamat- Gan, Ramat-almogi, IsraelChaim Sheba Med. center. Dept. Of Dermatology
Jul 19, 2018
Hypercholesterolemia Trial in Worldwide (ALIROCUMAB SAR236553 (REGN727), (for injection training only), ezetimibe)
Completed
- Hypercholesterolemia
- ALIROCUMAB SAR236553 (REGN727)
- +5 more
-
Graz, Austria
- +152 more
Mar 21, 2022
Pityriasis Lichenoides : Anatomo-clinical Aspects and Follow-up
Unknown status
- Pityriasis Lichenoides
- (no location specified)
Apr 15, 2019
Chronic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)
Completed
- Chronic Kidney Disease
- Finerenone (BAY94-8862)
- Placebo
-
Birmingham, Alabama
- +977 more
Jun 29, 2021
Psoriatic Arthritis Trial in Worldwide (Etanercept, Methotrexate, Placebo to Etanercept)
Coronary Artery Disease, Myocardial Ischemia Trial in Japan (XIENCE PRIME®/XIENCE Xpedition™, Absorb™ BVS)
Completed
- Coronary Artery Disease
- Myocardial Ischemia
- XIENCE PRIME®/XIENCE Xpedition™
- Absorb™ BVS
-
Nagoya-shi, Aichi, Japan
- +38 more
Oct 5, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Moderate Risk of CVD Trial in Worldwide (Aspirin (Acetylsalicylic acid, BAYE4465), Placebo)
Completed
- Moderate Risk of CVD
- Aspirin (Acetylsalicylic acid, BAYE4465)
- Placebo
-
Birmingham, Alabama
- +465 more
Sep 26, 2018
Type 2 Diabetes Trial in Worldwide (Exenatide Once Weekly, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Exenatide Once Weekly
- Placebo
-
Birmingham, Alabama
- +629 more
Jul 13, 2018
COPD (COPD) Trial in Worldwide (QVA149, Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS))
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- QVA149
- Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS)
-
Caba, Buenos Aires, Argentina
- +495 more
May 5, 2016
Hepatitis C, Chronic Trial in Worldwide (BI 201335 NA 240 mg QD / LI, PegIFN/RBV, BI 201335 NA 120mg QD / LI)
Completed
- Hepatitis C, Chronic
- BI 201335 NA 240 mg QD / LI
- +5 more
-
San Francisco, California
- +99 more
Oct 14, 2015
Parapsoriasis Trial in Philadelphia (Bexarotene 1% gel)
Terminated
- Parapsoriasis
- Bexarotene 1% gel
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 15, 2013
CHF Trial in Worldwide (Irbesartan, Placebo)
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (tiotropium, )
Completed
- Pulmonary Disease, Chronic Obstructive
- tiotropium
- placebo
-
Anniston, Alabama
- +489 more
May 15, 2014
Cardiovascular Diseases Trial in Worldwide (Telmisartan, Combination of Telmisartan and Ramipril, Ramipril)
Postmenopausal Osteoporosis Trial in Worldwide (risedronate)
Completed
- Postmenopausal Osteoporosis
-
Birmingham, Alabama
- +44 more
Apr 15, 2013
Multiple Sclerosis Trial in Worldwide (Fingolimod 0.5 mg, Fingolimod 1.25 mg)
Completed
- Multiple Sclerosis
- Fingolimod 0.5 mg
- Fingolimod 1.25 mg
-
Chatswood, Australia
- +104 more
Jun 9, 2012